IP Verse

Nutraceutical Or Pharmaceutical Composition For Use In The Treatment Of Polycystic Ovary Syndrome Or Of Diseases Or Disorders Related Thereto - EP3452012

The patent EP3452012 was granted to S&R Farmaceutici on Jun 23, 2021. The application was originally filed on Apr 13, 2017 under application number EP17727376A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3452012

S&R FARMACEUTICI
Application Number
EP17727376A
Filing Date
Apr 13, 2017
Status
Opposition Rejected
Feb 9, 2024
Publication Date
Jun 23, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LOLI PHARMAMar 22, 2022PACE NAPOLEONEADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2875809
INTERNATIONAL-SEARCH-REPORTEP3130336
INTERNATIONAL-SEARCH-REPORTIN1312MUM2014
INTERNATIONAL-SEARCH-REPORTWO2012107905
INTERNATIONAL-SEARCH-REPORTWO2013076121
OPPOSITIONEP2679243
OPPOSITIONIT1391323
OPPOSITIONWO2013152055

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "Female infertility but not only... discover the polycystic ovary syndrome", S&R Farmaceutici » NL|10 - 28 june 2016, URL: http://www.srfarmaceutici.it/nl10-28-june-2016/?lang=en, (20161202), XP055325540
OPPOSITION- Costantino D; Minozzi G; Minozzi F; Guaraldi C, "Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: A double-blind trial", European Review for Medical and Pharmacological Sciences, IT , (20090101), vol. 13, no. 2, ISSN 1128-3602, pages 105 - 110, XP008170554
OPPOSITION- Minozzi M; Nordio M; Pajalich R, "The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.", European Review for Medical and Pharmacological Sciences, IT , (20130201), vol. 17, no. 4, ISSN 1128-3602, pages 537 - 540, XP009168787
OPPOSITION- Parazzini F, "Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause", Minerva Ginecol, (20140101), vol. 66, no. 5, pages 513 - 518, XP055909077
OPPOSITION- Unfer Vittorio, Porcaro Giuseppina, "Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome", Expert Rev Clin Pharmacol, (20140901), vol. 7, no. 5, pages 623 - 631, XP055909075

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents